Durham, N.C., June 09, 2021 The HIV Prevention Trials Network announced today the launch of HPTN 094 , a study to determine whether using mobile health units to deliver integrated health.
In the summer of 1981, public health professionals faced a terrifying crisis. Their work helped shape victories against the current pandemic – but some fear hard-won ground is lost
May 27 North Carolina reported its 1 millionth positive test for COVID-19 on Thursday, 450 days after reporting its first. More than 13,000 North Carolinians have died due to the virus, according to the state Department of Health and Human Services. The pandemic has had a broad effect on society, including public health, the economy, education and politics. Dr. Myron Cohen, director of the .
Speed Reads
There could one day be a COVID-19 equivalent to a carbon monoxide detector.
General Electric is developing a new sensor which could potentially detect the coronavirus and other viruses in the air, on a surface, or on someone s breath,
Fast Company reports. The National Institutes of Health awarded the company a two-year research grant to work on the project, which will build upon two papers published by GE s principal scientist, Radislav Potyrailo, and his team.
The sensor that would detect the virus would be a microchip smaller than a dime,
Fast Company reports. Potyrailo is hopeful about the long-term prospects of the project, but he acknowledged the system is hard to build because it needs to be small enough to keep larger contaminants like pollen out to ensure only the right particles are detected.
Regeneron Antibody Cocktail Offers COVID Protection
April 13, 2021 - People living with someone who has COVID-19 appear to get powerful protection against infection when they are given Regeneron s antibody cocktail, a new study shows.
The findings suggest that beyond preventing the worst outcomes for coronavirus infection when given early enough, the cocktail could also prevent people from getting sick in the first place, the company said Monday. With more than 60,000 Americans continuing to be diagnosed with COVID-19 every day, the REGEN-COV antibody cocktail may help provide immediate protection to unvaccinated people who are exposed to the virus, and we are also working to understand its potential to provide ongoing protection for immunocompromised patients who may not respond well to vaccines, Dr. George Yancopoulos, president and chief scientific officer at Regeneron, said in a statement.